Volume 21: Issue 4 (Sep 2022): Hypertension

Guyton AC: Blood pressure control: Pecial role of the kidneys and body fluids. Science 252: 1813–1816, 1991 PubMed

• PubMed
Guyton AC: Blood pressure control: Pecial role of the kidneys and body fluids. Science 252: 1813–1816, 1991 PubMed)| false
• Search Google Scholar
• Export Citation

Padmanabhan S, Dominiczak AF: Genomics of hypertension: The road to precision medicine. Nat Rev Cardiol 18: 235–250, 2021 PubMed

• PubMed
Padmanabhan S, Dominiczak AF: Genomics of hypertension: The road to precision medicine. Nat Rev Cardiol 18: 235–250, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ: Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 45: 80–85, 2005 PubMed

• PubMed
Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJ: Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 45: 80–85, 2005 PubMed)| false
• Search Google Scholar
• Export Citation

Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al.; Million Veteran Program: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet 50: 1412–1425, 2018 PubMed

• PubMed
Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, ; Million Veteran Program: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet 50: 1412–1425, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Vaura F, Kauko A, Suvila K, Havulinna AS, Mars N, Salomaa V, et al.: Polygenic risk scores predict hypertension onset and cardiovascular risk. Hypertension 77: 1119–1127, 2021 PubMed

• PubMed
Vaura F, Kauko A, Suvila K, Havulinna AS, Mars N, Salomaa V, : Polygenic risk scores predict hypertension onset and cardiovascular risk. Hypertension 77: 1119–1127, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Warrington NM, Beaumont RN, Horikoshi M, Day FR, Helgeland Ø, Laurin C, et al.; EGG Consortium: Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat Genet 51: 804–814, 2019 PubMed

• PubMed
Warrington NM, Beaumont RN, Horikoshi M, Day FR, Helgeland Ø, Laurin C, ; EGG Consortium: Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat Genet 51: 804–814, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 348: 101–108, 2003 PubMed

• PubMed
Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 348: 101–108, 2003 PubMed)| false
• Search Google Scholar
• Export Citation

Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, et al.; Global BPgen Consortium: Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 6: e1001177, 2010 PubMed

• PubMed
Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, ; Global BPgen Consortium: Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 6: e1001177, 2010 PubMed)| false
• Search Google Scholar
• Export Citation

Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS, et al.: Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 63: 551–558, 2014 PubMed

• PubMed
Graham LA, Padmanabhan S, Fraser NJ, Kumar S, Bates JM, Raffi HS, : Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 63: 551–558, 2014 PubMed)| false
• Search Google Scholar
• Export Citation

Devuyst O, Olinger E, Rampoldi L: Uromodulin: From physiology to rare and complex kidney disorders. Nat Rev Nephrol 13: 525–544, 2017 PubMed

• PubMed
Devuyst O, Olinger E, Rampoldi L: Uromodulin: From physiology to rare and complex kidney disorders. Nat Rev Nephrol 13: 525–544, 2017 PubMed)| false
• Search Google Scholar
• Export Citation

Torffvit O, Melander O, Hultén UL: Urinary excretion rate of Tamm-Horsfall protein is related to salt intake in humans. Nephron, Physiol 97: 31–36, 2004 PubMed

• PubMed
Torffvit O, Melander O, Hultén UL: Urinary excretion rate of Tamm-Horsfall protein is related to salt intake in humans. Nephron, Physiol 97: 31–36, 2004 PubMed)| false
• Search Google Scholar
• Export Citation

Bakhoum CY, Anderson CAM, Juraschek SP, Rebholz CM, Appel LJ, Miller ER, et al.: The relationship between urine uromodulin and blood pressure changes: The DASH-sodium trial. Am J Hypertens 34: 154–156, 2021 PubMed

• PubMed
Bakhoum CY, Anderson CAM, Juraschek SP, Rebholz CM, Appel LJ, Miller ER, : The relationship between urine uromodulin and blood pressure changes: The DASH-sodium trial. Am J Hypertens 34: 154–156, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al.; DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344: 3–10, 2001 PubMed

• PubMed
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, ; DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344: 3–10, 2001 PubMed)| false
• Search Google Scholar
• Export Citation

Ponte B, Pruijm M, Ackermann D, Olinger E, Youhanna S, Vogt B, et al.: Uromodulin, salt, and 24-hour blood pressure in the general population. Clin J Am Soc Nephrol 16: 787–789, 2021 PubMed

• PubMed
Ponte B, Pruijm M, Ackermann D, Olinger E, Youhanna S, Vogt B, : Uromodulin, salt, and 24-hour blood pressure in the general population. Clin J Am Soc Nephrol 16: 787–789, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Stsiapanava A, Xu C, Brunati M, Zamora-Caballero S, Schaeffer C, Bokhove M, et al.: Cryo-EM structure of native human uromodulin, a zona pellucida module polymer. EMBO J 39: e106807, 2020 PubMed

• PubMed
Stsiapanava A, Xu C, Brunati M, Zamora-Caballero S, Schaeffer C, Bokhove M, : Cryo-EM structure of native human uromodulin, a zona pellucida module polymer. EMBO J 39: e106807, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Micanovic R, LaFavers K, Garimella PS, Wu XR, El-Achkar TM: Uromodulin (Tamm-Horsfall protein): Guardian of urinary and systemic homeostasis. Nephrol Dial Transplant 35: 33–43, 2020 PubMed

• PubMed
Micanovic R, LaFavers K, Garimella PS, Wu XR, El-Achkar TM: Uromodulin (Tamm-Horsfall protein): Guardian of urinary and systemic homeostasis. Nephrol Dial Transplant 35: 33–43, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Singh P, Harris PC, Sas DJ, Lieske JC: The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18: 224–240, 2022 PubMed

• PubMed
Singh P, Harris PC, Sas DJ, Lieske JC: The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18: 224–240, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Gonzalez-Jaramillo V, Portilla-Fernandez E, Glisic M, Voortman T, Bramer W, Chowdhury R, et al.: The role of DNA methylation and histone modifications in blood pressure: A systematic review. J Hum Hypertens 33: 703–715, 2019 PubMed

• PubMed
Gonzalez-Jaramillo V, Portilla-Fernandez E, Glisic M, Voortman T, Bramer W, Chowdhury R, : The role of DNA methylation and histone modifications in blood pressure: A systematic review. J Hum Hypertens 33: 703–715, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Sedaka R, Hyndman KA, Mironova E, Stockand JD, Pollock JS: High salt intake induces collecting duct HDAC1-dependent NO signaling. Am J Physiol Renal Physiol 320: F297–F307, 2021 PubMed

• PubMed
Sedaka R, Hyndman KA, Mironova E, Stockand JD, Pollock JS: High salt intake induces collecting duct HDAC1-dependent NO signaling. Am J Physiol Renal Physiol 320: F297–F307, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Fang Z, Wang X, Sun X, Hu W, Miao QR: The role of histone protein acetylation in regulating endothelial function. Front Cell Dev Biol 9: 672447, 2021 PubMed

• PubMed
Fang Z, Wang X, Sun X, Hu W, Miao QR: The role of histone protein acetylation in regulating endothelial function. Front Cell Dev Biol 9: 672447, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Kawarazaki W, Fujita T: Kidney and epigenetic mechanisms of salt-sensitive hypertension. Nat Rev Nephrol 17: 350–363, 2021 PubMed

• PubMed
Kawarazaki W, Fujita T: Kidney and epigenetic mechanisms of salt-sensitive hypertension. Nat Rev Nephrol 17: 350–363, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Kawakami-Mori F, Nishimoto M, Reheman L, Kawarazaki W, Ayuzawa N, Ueda K, et al.: Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension. JCI Insight 3: e95625, 2018 PubMed

• PubMed
Kawakami-Mori F, Nishimoto M, Reheman L, Kawarazaki W, Ayuzawa N, Ueda K, : Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension. JCI Insight 3: e95625, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Dasinger JH, Alsheikh AJ, Abais-Battad JM, Pan X, Fehrenbach DJ, Lund H, et al.: Epigenetic modifications in T cells: The role of DNA methylation in salt-sensitive hypertension. Hypertension 75: 372–382, 2020 PubMed

• PubMed
Dasinger JH, Alsheikh AJ, Abais-Battad JM, Pan X, Fehrenbach DJ, Lund H, : Epigenetic modifications in T cells: The role of DNA methylation in salt-sensitive hypertension. Hypertension 75: 372–382, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Mao SQ, Sun JH, Gu TL, Zhu FB, Yin FY, Zhang LN: Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: A matched case-control study. J Hum Hypertens 31: 530–536, 2017 PubMed

• PubMed
Mao SQ, Sun JH, Gu TL, Zhu FB, Yin FY, Zhang LN: Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: A matched case-control study. J Hum Hypertens 31: 530–536, 2017 PubMed)| false
• Search Google Scholar
• Export Citation

Treesaranuwattana T, Wong KYH, Brooks DL, Tay CS, Williams GH, Williams JS, et al.: Lysine-specific demethylase-1 deficiency increases agonist signaling via the mineralocorticoid receptor. Hypertension 75: 1045–1053, 2020 PubMed

• PubMed
Treesaranuwattana T, Wong KYH, Brooks DL, Tay CS, Williams GH, Williams JS, : Lysine-specific demethylase-1 deficiency increases agonist signaling via the mineralocorticoid receptor. Hypertension 75: 1045–1053, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, et al.; American Heart Association Professional and Public Education Committee of the Council on Hypertension; Council on Functional Genomics and Translational Biology; and Stroke Council: Salt sensitivity of blood pressure: A scientific statement from the American Heart Association. Hypertension 68: e7–e46, 2016 PubMed

• PubMed
Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, ; American Heart Association Professional and Public Education Committee of the Council on Hypertension; Council on Functional Genomics and Translational Biology; and Stroke Council: Salt sensitivity of blood pressure: A scientific statement from the American Heart Association. Hypertension 68: e7–e46, 2016 PubMed)| false
• Search Google Scholar
• Export Citation

Laffer CL, Scott 3rd RC, Titze JM, Luft FC, Elijovich F: Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects. Hypertension 68: 195–203, 2016 PubMed

• PubMed
Laffer CL, Scott 3rd RC, Titze JM, Luft FC, Elijovich F: Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects. Hypertension 68: 195–203, 2016 PubMed)| false
• Search Google Scholar
• Export Citation

Thomson SC, Vallon V: Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats. Am J Physiol Renal Physiol 320: F761–F771, 2021 PubMed

• PubMed
Thomson SC, Vallon V: Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats. Am J Physiol Renal Physiol 320: F761–F771, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Wilcox CS: Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension 75: 894–901, 2020 PubMed

• PubMed
Wilcox CS: Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension 75: 894–901, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, et al.: Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med 385: 2507–2519, 2021 PubMed

• PubMed
Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, : Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med 385: 2507–2519, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Bovée DM, Uijl E, Severs D, Rubio-Beltrán E, van Veghel R, Maassen van den Brink A, et al.: Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. Am J Physiol Renal Physiol 320: F654–F668, 2021 PubMed

• PubMed
Bovée DM, Uijl E, Severs D, Rubio-Beltrán E, van Veghel R, Maassen van den Brink A, : Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. Am J Physiol Renal Physiol 320: F654–F668, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Harrison DG, Coffman TM, Wilcox CS: Pathophysiology of hypertension: The mosaic theory and beyond. Circ Res 128: 847–863, 2021 PubMed

• PubMed
Harrison DG, Coffman TM, Wilcox CS: Pathophysiology of hypertension: The mosaic theory and beyond. Circ Res 128: 847–863, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Agarwal M, Thareja N, Benjamin M, Akhondi A, Mitchell GD: Tyrosine kinase inhibitor-induced hypertension. Curr Oncol Rep 20: 65, 2018 PubMed

• PubMed
Agarwal M, Thareja N, Benjamin M, Akhondi A, Mitchell GD: Tyrosine kinase inhibitor-induced hypertension. Curr Oncol Rep 20: 65, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, et al.: Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease. Hypertension 71: e1–e8, 2018 PubMed

• PubMed
Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, : Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease. Hypertension 71: e1–e8, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Mäki-Petäjä KM, McGeoch A, Yang LL, Hubsch A, McEniery CM, Meyer PAR, et al.: Mechanisms underlying vascular endothelial growth factor receptor inhibition-induced hypertension: The HYPAZ trial. Hypertension 77: 1591–1599, 2021 PubMed

• PubMed
Mäki-Petäjä KM, McGeoch A, Yang LL, Hubsch A, McEniery CM, Meyer PAR, : Mechanisms underlying vascular endothelial growth factor receptor inhibition-induced hypertension: The HYPAZ trial. Hypertension 77: 1591–1599, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Quintanilha JCF, Liu Y, Etheridge AS, Yazdani A, Kindler HL, Kelly WK, et al.: Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). Angiogenesis 25: 47–55, 2022 PubMed

• PubMed
Quintanilha JCF, Liu Y, Etheridge AS, Yazdani A, Kindler HL, Kelly WK, : Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). Angiogenesis 25: 47–55, 2022 PubMed)| false
• Search Google Scholar
• Export Citation

Ruggeri Barbaro N, Van Beusecum J, Xiao L, do Carmo L, Pitzer A, Loperena R, et al.: Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovasc Res 117: 1358–1371, 2021 PubMed

• PubMed
Ruggeri Barbaro N, Van Beusecum J, Xiao L, do Carmo L, Pitzer A, Loperena R, : Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation. Cardiovasc Res 117: 1358–1371, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Wenzel UO, Bode M, Kurts C, Ehmke H: Salt, inflammation, IL-17 and hypertension. Br J Pharmacol 176: 1853–1863, 2019 PubMed

• PubMed
Wenzel UO, Bode M, Kurts C, Ehmke H: Salt, inflammation, IL-17 and hypertension. Br J Pharmacol 176: 1853–1863, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Ferguson JF, Aden LA, Barbaro NR, Van Beusecum JP, Xiao L, Simmons AJ, et al.: High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension. JCI Insight 5: e126241, 2019 PubMed

• PubMed
Ferguson JF, Aden LA, Barbaro NR, Van Beusecum JP, Xiao L, Simmons AJ, : High dietary salt-induced dendritic cell activation underlies microbial dysbiosis-associated hypertension. JCI Insight 5: e126241, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, et al.: Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551: 585–589, 2017 PubMed

• PubMed
Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, : Salt-responsive gut commensal modulates T_H17 axis and disease. Nature 551: 585–589, 2017 PubMed)| false
• Search Google Scholar
• Export Citation

Rothman AM, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, et al.: Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: A secondary analysis of CANTOS. Hypertension 75: 477–482, 2020 PubMed

• PubMed
Rothman AM, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, : Effects of interleukin-1β inhibition on blood pressure, incident hypertension, and residual inflammatory risk: A secondary analysis of CANTOS. Hypertension 75: 477–482, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Prieto MC, Gonzalez AA, Visniauskas B, Navar LG: The evolving complexity of the collecting duct renin-angiotensin system in hypertension. Nat Rev Nephrol 17: 481–492, 2021 PubMed

• PubMed
Prieto MC, Gonzalez AA, Visniauskas B, Navar LG: The evolving complexity of the collecting duct renin-angiotensin system in hypertension. Nat Rev Nephrol 17: 481–492, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Kemp BA, Howell NL, Keller SR, Gildea JJ, Shao W, Navar LG, et al.: Defective renal angiotensin III and AT2 receptor signaling in prehypertensive spontaneously hypertensive rats. J Am Heart Assoc 8: e012016, 2019 PubMed

• PubMed
Kemp BA, Howell NL, Keller SR, Gildea JJ, Shao W, Navar LG, : Defective renal angiotensin III and AT₂ receptor signaling in prehypertensive spontaneously hypertensive rats. J Am Heart Assoc 8: e012016, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Uijl E, Ren L, Danser AHJ: Angiotensin generation in the brain: A re-evaluation. Clin Sci (Lond) 132: 839–850, 2018 PubMed

• PubMed
Uijl E, Ren L, Danser AHJ: Angiotensin generation in the brain: A re-evaluation. Clin Sci (Lond) 132: 839–850, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Rodrigues AF, Todiras M, Qadri F, Campagnole-Santos MJ, Alenina N, Bader M: Increased angiotensin II formation in the brain modulates cardiovascular homeostasis and erythropoiesis. Clin Sci (Lond) 135: 1353–1367, 2021 PubMed

• PubMed
Rodrigues AF, Todiras M, Qadri F, Campagnole-Santos MJ, Alenina N, Bader M: Increased angiotensin II formation in the brain modulates cardiovascular homeostasis and erythropoiesis. Clin Sci (Lond) 135: 1353–1367, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Uijl E, Ren L, Mirabito Colafella KM, van Veghel R, Garrelds IM, Domenig O, et al.: No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension. Clin Sci (Lond) 135: 259–274, 2021 PubMed

• PubMed
Uijl E, Ren L, Mirabito Colafella KM, van Veghel R, Garrelds IM, Domenig O, : No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension. Clin Sci (Lond) 135: 259–274, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group: Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension 42: 239–246, 2003 PubMed

• PubMed
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group: Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension 42: 239–246, 2003 PubMed)| false
• Search Google Scholar
• Export Citation

Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al.; ACCOMPLISH Trial Investigators: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359: 2417–2428, 2008 PubMed

• PubMed
Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, ; ACCOMPLISH Trial Investigators: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359: 2417–2428, 2008 PubMed)| false
• Search Google Scholar
• Export Citation

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al.: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension 71: e13–e115, 2018 PubMed

• PubMed
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension 71: e13–e115, 2018 PubMed)| false
• Search Google Scholar
• Export Citation

Filippini T, Naska A, Kasdagli MI, Torres D, Lopes C, Carvalho C, et al.: Potassium intake and blood pressure: A dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc 9: e015719, 2020 PubMed

• PubMed
Filippini T, Naska A, Kasdagli MI, Torres D, Lopes C, Carvalho C, : Potassium intake and blood pressure: A dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc 9: e015719, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Gibbs J, Gaskin E, Ji C, Miller MA, Cappuccio FP: The effect of plant-based dietary patterns on blood pressure: A systematic review and meta-analysis of controlled intervention trials. J Hypertens 39: 23–37, 2021 PubMed

• PubMed
Gibbs J, Gaskin E, Ji C, Miller MA, Cappuccio FP: The effect of plant-based dietary patterns on blood pressure: A systematic review and meta-analysis of controlled intervention trials. J Hypertens 39: 23–37, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Snelson M, Muralitharan RR, Dinakis E, Nakai M, Jama HA, Shihata WA, et al.: Renal ACE2 (angiotensin-converting enzyme 2) expression is modulated by dietary fiber intake, gut microbiota, and their metabolites. Hypertension 77: e53–e55, 2021 PubMed

• PubMed
Snelson M, Muralitharan RR, Dinakis E, Nakai M, Jama HA, Shihata WA, : Renal ACE2 (angiotensin-converting enzyme 2) expression is modulated by dietary fiber intake, gut microbiota, and their metabolites. Hypertension 77: e53–e55, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Hall JE, Mouton AJ, da Silva AA, Omoto ACM, Wang Z, Li X, et al.: Obesity, kidney dysfunction, and inflammation: Interactions in hypertension. Cardiovasc Res 117: 1859–1876, 2021 PubMed

• PubMed
Hall JE, Mouton AJ, da Silva AA, Omoto ACM, Wang Z, Li X, : Obesity, kidney dysfunction, and inflammation: Interactions in hypertension. Cardiovasc Res 117: 1859–1876, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al.: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356–362, 2005 PubMed

• PubMed
Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, : Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356–362, 2005 PubMed)| false
• Search Google Scholar
• Export Citation

Kane AE, Sinclair DA: Epigenetic changes during aging and their reprogramming potential. Crit Rev Biochem Mol Biol 54: 61–83, 2019 PubMed

• PubMed
Kane AE, Sinclair DA: Epigenetic changes during aging and their reprogramming potential. Crit Rev Biochem Mol Biol 54: 61–83, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Wei J, Zhu J, Zhang J, Jiang S, Qu L, Wang L, et al.: Aging impairs renal autoregulation in mice. Hypertension 75: 405–412, 2020 PubMed

• PubMed
Wei J, Zhu J, Zhang J, Jiang S, Qu L, Wang L, : Aging impairs renal autoregulation in mice. Hypertension 75: 405–412, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Sato Y, Yanagita M: Immunology of the ageing kidney. Nat Rev Nephrol 15: 625–640, 2019 PubMed

• PubMed
Sato Y, Yanagita M: Immunology of the ageing kidney. Nat Rev Nephrol 15: 625–640, 2019 PubMed)| false
• Search Google Scholar
• Export Citation

Kawarazaki W, Mizuno R, Nishimoto M, Ayuzawa N, Hirohama D, Ueda K, et al.: Salt causes aging-associated hypertension via vascular Wnt5a under klotho deficiency. J Clin Invest 130: 4152–4166, 2020 PubMed

• PubMed
Kawarazaki W, Mizuno R, Nishimoto M, Ayuzawa N, Hirohama D, Ueda K, : Salt causes aging-associated hypertension via vascular Wnt5a under klotho deficiency. J Clin Invest 130: 4152–4166, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Kanbay M, Demiray A, Afsar B, Covic A, Tapoi L, Ureche C, et al.: Role of klotho in the development of essential hypertension. Hypertension 77: 740–750, 2021 PubMed

• PubMed
Kanbay M, Demiray A, Afsar B, Covic A, Tapoi L, Ureche C, : Role of klotho in the development of essential hypertension. Hypertension 77: 740–750, 2021 PubMed)| false
• Search Google Scholar
• Export Citation

Citterio L, Delli Carpini S, Lupoli S, Brioni E, Simonini M, Fontana S, et al.: Klotho gene in human salt-sensitive hypertension. Clin J Am Soc Nephrol 15: 375–383, 2020 PubMed

• PubMed
Citterio L, Delli Carpini S, Lupoli S, Brioni E, Simonini M, Fontana S, : Klotho gene in human salt-sensitive hypertension. Clin J Am Soc Nephrol 15: 375–383, 2020 PubMed)| false
• Search Google Scholar
• Export Citation

Simmonds SS, Lay J, Stocker SD: Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats. Hypertension 64: 583–589, 2014 PubMed

• PubMed
Simmonds SS, Lay J, Stocker SD: Dietary salt intake exaggerates sympathetic reflexes and increases blood pressure variability in normotensive rats. Hypertension 64: 583–589, 2014 PubMed)| false
• Search Google Scholar
• Export Citation

Cao W, Wu L, Zhang X, Zhou J, Wang J, Yang Z, et al.: Sympathetic overactivity in CKD disrupts buffering of neurotransmission by endothelium-derived hyperpolarizing factor and enhances vasoconstriction. J Am Soc Nephrol 31: 2312–2325, 2020 PubMed

• PubMed
Cao W, Wu L, Zhang X, Zhou J, Wang J, Yang Z, : Sympathetic overactivity in CKD disrupts buffering of neurotransmission by endothelium-derived hyperpolarizing factor and enhances vasoconstriction. J Am Soc Nephrol 31: 2312–2325, 2020 PubMed)| false
• Search Google Scholar
• Export Citation